Cedars-Sinai · 4 days ago
Revenue Cycle Analyst
Los Angeles, CA
Full-time
Onsite
Entry, Mid Level
$77K/yr - $119K/yr
1+ years expCedars-Sinai is a leading medical institution recognized for its excellence in healthcare. The Revenue Cycle Analyst is responsible for analyzing trends, developing reports, and making recommendations to improve revenue cycle efficiency.
CommunitiesHealth CareMedicalNon Profit
Responsibilities
Analyzing trends to determine where variances are occurring and develop reports to assess these variances
Summarizing information, data, and recommendations, and preparing presentation materials. May present findings to management
Making recommendations based upon overall analysis to effectively monitor areas of opportunity/risk
Creating/developing regular and ad-hoc reports
Payor Policy analysis and review
Denial and Revenue Cycle trending
Using independent judgment to resolve issues
Completing complex/special assignments
Qualification
Required
High School Diploma or GED required
A minimum of 1 year of proven experience as an analyst (revenue cycle, data, financial, business, or related) required
Preferred
Bachelor's degree in Finance, Economics, Business or a related field preferred
A minimum of 5 years of proven experience in PB Revenue Cycle preferred
Benefits
Health care
Dental
Vision
Paid time off
403(b)
Health
Vision
Dental
Life and insurance
Company
Cedars-Sinai
Since its beginning in 1902, Cedars-Sinai has evolved to meet the healthcare needs of one of the most diverse regions in the nation, continually setting new standards for quality and innovation in patient care, research, teaching and community service.
10001+ employees
H1B Sponsorship
Cedars-Sinai has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (105)
2024 (91)
2023 (81)
2022 (92)
2021 (92)
2020 (65)
Funding
Current Stage
Late StageTotal Funding
$63.31MKey Investors
American Academy of Orthopaedic SurgeonsCalifornia HealthCare FoundationNational Heart, Lung and Blood Institute
2023-12-01Grant· $0.01M
2023-05-25Grant· $28M
2022-06-16Grant· $7M
Leadership Team
Thomas Priselac
President/CEO
David Wrigley
Executive Vice President Finance, CFO and Treasurer
Recent News
Tech Startups - Tech News, Tech Trends & Startup Funding
2026-01-16
Tech Startups - Tech News, Tech Trends & Startup Funding
2026-01-16
Tech Startups - Tech News, Tech Trends & Startup Funding
2026-01-16
Company data provided by crunchbase